← 產業報告目錄

Blood Collection Devices Market by Product (Tubes (Plasma (EDTA, Heparin), Serum), Needles & Syringes, Blood Bags, Monitors), Method (Manual, Automated), Application (Diagnostics, Therapeutics), End User (Hospitals, Blood Banks) - Global Forecast to 2030

出版商 MarketsandMarkets產業別 Medical Devices出版日期 2025-11-04頁數 270報告編號 MD4465

授權報價

Single User Licence$4,950 USD
Multi User Licence$6,650 USD
Corporate User Licence$8,150 USD
Global User Licence$10,000 USD
洽詢購買 申請 Sample

報告摘要

The global blood collection devices market is projected to reach USD 13.02 billion by 2030 from USD 9.13 billion in 2025, at a CAGR of 7.4% during the forecast period. The blood collection devices market is driven by several key factors. The rising prevalence of infectious diseases, along with chronic and lifestyle-related conditions, has increased the need for frequent and reliable blood testing. At the same time, the growing number of hospitals and surgical centers worldwide is expanding healthcare infrastructure, creating greater demand for efficient blood collection solutions. The rise in accidents and trauma cases has further heightened the need for rapid and safe blood collection for emergency care and transfusions. Additionally, the emergence of liquid biopsy tests, which use blood samples for early cancer detection and monitoring, is driving the demand for advanced collection devices that ensure sample quality and accuracy. Growing awareness and the demand for blood donations and blood components are also contributing to the overall expansion of the market, particularly in emerging regions. The automated blood collection segment is expected to grow at the highest rate during the forecast period. The blood collection devices available in the market are based on two major methods: manual and automated blood collection methods. The automated blood collection segment is projected to register a higher CAGR during the forecast period. The growth of the automated blood collection segment can be attributed to the increasing demand for safer procedures and the availability of advanced blood collection products. However, the most widely used method in the blood collection devices market is manual blood collection. This segment accounted for the largest share of the market in 2024. The hospitals, ASCs, and nursing homes segment accounted for the largest share of the blood collection devices market in 2024. The hospitals, ASCs, and nursing homes segment accounted for the largest share of the blood collection devices market in 2024. The increasing incidence of infectious diseases and the rise in the number of trauma cases, as well as C-sections and organ transplants, have ensured the demand for blood collection equipment and devices in hospital facilities. This, along with expanded capabilities, is driving the growth of this market. North America dominated the blood collection devices market in 2024. North America, comprising the US and Canada, accounted for the largest share of the global blood collection devices market in 2024, followed by Europe. Factors such as the increasing prevalence of lifestyle diseases and the rising incidence of blood disorders, better healthcare facilities, and the presence of major manufacturers in the region are stimulating the growth of the blood collection devices market in North America. However, the Asia Pacific market is expected to grow at the highest CAGR during the forecast period. Breakdown of supply-side primary interviews, by company type, designation, and region: • By Company Type: Tier 1 (40%), Tier 2 (30%), and Tier 3 (30%) • By Designation: C-level Executives (27%), Director-level Executives (18%), and Others (55%) • By Region: North America (51%), Europe (21%), Asia Pacific (18%), Latin America (6%), and the Middle East & Africa (4%) List of Companies Profiled in the Report • Fresenius Kabi AG (Germany) • Becton, Dickinson and Company (US) • Terumo BCT, Inc. (Japan) • Greiner Holding (Austria) • Cardinal Health (US) • Haemonetics Corporation (US) • Grifols, S.A (Spain) • Nipro Medical Corporation (Japan) • SARSTEDT AG & Co. (Germany) • Macopharma (France) • ICU Medical, Inc. (US) • Retractable Technologies, Inc. (US) • Liuyang Sanli Medical Technology Development (China) • F.L. Medical s.r.l. (Italy) • AB Medical Co., Ltd. (South Korea) • Aptaca SPA (Italy) • Jiangsu Micsafe Medical Technology Co., Ltd. (China) • Disera Tibbi Malzeme Lojistik Sanayi Ve Ticaret A.Ş (Turkey) • Ajosha Bio Teknik Pvt. Ltd. (India) • Preq Systems (India) • CML Biotech (India) • Lmb Technologie GmbH (Germany) • Mitra Industries Private Limited (India) • Neomedic Limited (UK) Research Coverage This research report categorizes the blood collection devices market by product (blood collection tubes, needles & syringes, blood bags, blood collection systems/monitors, and lancets), method (manual blood collection and automated blood collection), application (diagnostic applications and therapeutic applications), end user (hospitals, ASCs, and nursing homes; blood banks; diagnostic & pathology laboratories; and other end users), and region (North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa). The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, opportunities, and challenges, influencing the growth of the blood collection devices market. A detailed analysis of the key industry players has been done to provide insights into their business overview, products offered, key strategies, acquisitions, and partnerships. This report covers the competitive analysis of upcoming startups in the blood collection devices market ecosystem. Key Benefits of Buying the Report The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall blood collection devices market and subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities. The report provides insights into the following pointers: • Analysis of key drivers (rising prevalence of infectious diseases and chronic & lifestyle diseases, increasing number of hospitals and surgical centers, rise in accidents and trauma cases, emergence of liquid biopsy tests, and growing demand for and awareness of blood donations and blood components), restraints (high cost of automated blood collection devices), opportunities (increasing demand for apheresis, lucrative opportunities in emerging economies, and advancements in blood collection procedures and products), and challenges (complex storage and shipping and lack of skilled professionals) influencing the growth of the blood collection devices market. • Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product launches in the blood collection devices market. • Market Development: Comprehensive information about lucrative markets; the report analyzes the blood collection devices market across varied regions. • Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the blood collection devices market. • Competitive Assessment: In-depth assessment of market shares, growth strategies, and product offerings of leading players, such as Fresenius Kabi AG (Germany), Becton, Dickinson and Company (ND) (US), Terumo BCT, Inc. (Japan), Greiner Holding AG (Austria), Cardinal Health (US), Haemonetics Corporation (US), Grifols, S.A. (Spain), Nipro Medical Corporation (Japan), SARSTEDT AG & Co. KG (Germany), Macopharma (France), ICU Medical, Inc. (US), and Retractable Technologies, Inc. (US), among others.
目錄 Table of Contents
1 INTRODUCTION 28 1.1 STUDY OBJECTIVES 28 1.2 MARKET DEFINITION 28 1.3 MARKET SCOPE 29 1.3.1 MARKET SEGMENTATION AND REGIONAL SCOPE 29 1.3.2 INCLUSIONS AND EXCLUSIONS 30 1.3.3 YEARS CONSIDERED 30 1.4 CURRENCY CONSIDERED 30 1.5 STAKEHOLDERS 31 1.6 SUMMARY OF CHANGES 31 2 RESEARCH METHODOLOGY 32 2.1 RESEARCH DATA 32 2.1.1 SECONDARY RESEARCH 33 2.1.1.1 Key data from secondary sources 34 2.1.2 PRIMARY RESEARCH 34 2.1.2.1 Primary sources 34 2.1.2.2 Key objectives of primary research 35 2.1.2.3 Key data from primary sources 35 2.1.2.4 Key industry insights 36 2.2 MARKET SIZE ESTIMATION 37 2.2.1 BOTTOM-UP APPROACH 38 2.2.1.1 Approach 2: Presentations of companies and primary interviews 38 2.2.1.2 Growth forecast 39 2.2.2 TOP-DOWN APPROACH 39 2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 41 2.4 MARKET SHARE ESTIMATION 41 2.5 RESEARCH ASSUMPTIONS 42 2.5.1 PARAMETRIC ASSUMPTIONS 42 2.5.2 GROWTH RATE ASSUMPTIONS 42 2.6 RESEARCH LIMITATIONS 42 2.7 RISK ANALYSIS 43 3 EXECUTIVE SUMMARY 44 4 PREMIUM INSIGHTS 47 4.1 BLOOD COLLECTION DEVICES MARKET OVERVIEW 47 4.2 BLOOD COLLECTION DEVICES MARKET, BY PRODUCT, 2025 VS. 2030 48 4.3 BLOOD COLLECTION DEVICES MARKET, BY METHOD, 2025 VS. 2030 48 4.4 BLOOD COLLECTION DEVICES MARKET, BY APPLICATION, 2025 VS. 2030 49 4.5 BLOOD COLLECTION DEVICES MARKET, BY END USER, 2025 VS. 2030 49 4.6 BLOOD COLLECTION DEVICES MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 50 5 MARKET OVERVIEW 51 5.1 INTRODUCTION 51 5.2 MARKET DYNAMICS 51 5.2.1 DRIVERS 52 5.2.1.1 Rising prevalence of infectious diseases and chronic & lifestyle diseases 52 5.2.1.2 Increasing number of hospitals and surgical centers 54 5.2.1.3 Rise in accidents and trauma cases 55 5.2.1.4 Emergence of liquid biopsy tests 55 5.2.1.5 Growing demand for and awareness of blood donations and blood components 55 5.2.2 RESTRAINTS 57 5.2.2.1 Rising costs of automated blood collection devices 57 5.2.3 OPPORTUNITIES 57 5.2.3.1 Increasing demand for apheresis 57 5.2.3.2 Lucrative opportunities in emerging economies 57 5.2.3.3 Advancements in blood collection 58 5.2.4 CHALLENGES 58 5.2.4.1 Complex storage and shipping 58 5.2.4.2 Lack of skilled professionals 59 5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 59 5.4 PRICING ANALYSIS 60 5.4.1 AVERAGE SELLING PRICE TREND, BY PRODUCT 60 5.4.2 AVERAGE SELLING PRICE TREND OF BLOOD COLLECTION DEVICES, BY KEY PLAYER 60 5.4.3 AVERAGE SELLING PRICE TREND, BY REGION 61 5.5 VALUE CHAIN ANALYSIS 62 5.6 SUPPLY CHAIN ANALYSIS 63 5.7 ECOSYSTEM ANALYSIS 64 5.8 INVESTMENT AND FUNDING SCENARIO 65 5.9 TECHNOLOGY ANALYSIS 66 5.9.1 KEY TECHNOLOGIES 66 5.9.1.1 Core blood collection devices 66 5.9.2 COMPLEMENTARY TECHNOLOGIES 66 5.9.2.1 Sampling and collection kits 66 5.10 PATENT ANALYSIS 66 5.11 TRADE ANALYSIS 68 5.11.1 IMPORT DATA 69 5.11.2 EXPORT DATA 69 5.12 KEY CONFERENCES AND EVENTS, 2025–2026 69 5.13 CASE STUDY ANALYSIS 70 5.13.1 CASE STUDY 1: REDUCING HOSPITAL-ONSET BACTEREMIA USING PIVO NEEDLELESS BLOOD COLLECTION 70 5.13.2 CASE STUDY 2: ADOPTION OF PIVO NEEDLE-FREE BLOOD COLLECTION DEVICE AT VIRGINIA MASON MEDICAL CENTER 70 5.13.3 CASE STUDY 3: AUTONOMOUS BLOOD COLLECTION ENHANCES EFFICIENCY AND PATIENT EXPERIENCE AT ST. ANTONIUS HOSPITAL 71 5.14 REGULATORY ANALYSIS 71 5.14.1 REGULATORY LANDSCAPE 71 5.14.1.1 North America 71 5.14.1.1.1 US 71 5.14.1.1.2 Canada 72 5.14.1.2 Europe 72 5.14.1.2.1 Germany 72 5.14.1.2.2 UK 73 5.14.1.2.3 France 73 5.14.1.2.4 Italy 73 5.14.1.2.5 Spain 74 5.14.1.3 Asia Pacific 74 5.14.1.3.1 China 74 5.14.1.3.2 Japan 74 5.14.1.3.3 India 75 5.14.1.4 Latin America 75 5.14.1.4.1 Brazil 75 5.14.1.4.2 Mexico 75 5.14.1.5 Middle East 75 5.14.1.6 Africa 76 5.14.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 76 5.15 PORTER’S FIVE FORCES ANALYSIS 78 5.15.1 BARGAINING POWER OF SUPPLIERS 79 5.15.2 BARGAINING POWER OF BUYERS 79 5.15.3 THREAT OF NEW ENTRANTS 79 5.15.4 THREAT OF SUBSTITUTES 79 5.15.5 INTENSITY OF COMPETITIVE RIVALRY 79 5.16 KEY STAKEHOLDERS AND BUYING CRITERIA 80 5.16.1 KEY STAKEHOLDERS IN BUYING PROCESS 80 5.16.2 BUYING CRITERIA 80 5.17 IMPACT OF GENERATIVE AI ON BLOOD COLLECTION DEVICES MARKET 81 5.17.1 INTRODUCTION 81 5.17.2 MARKET POTENTIAL FOR BLOOD COLLECTION DEVICES 81 5.17.3 AI USE CASES 82 5.17.4 KEY COMPANIES IMPLEMENTING AI 83 5.17.5 FUTURE OF GENERATIVE AI IN BLOOD COLLECTION DEVICES MARKET 83 5.18 IMPACT OF 2025 US TARIFFS ON BLOOD COLLECTION DEVICES MARKET 83 5.18.1 INTRODUCTION 83 5.18.2 KEY TARIFF RATES 84 5.18.3 PRICE IMPACT ANALYSIS 85 5.18.4 IMPACT ON COUNTRY/REGION 85 5.18.4.1 North America 85 5.18.4.2 Europe 85 5.18.4.3 Asia Pacific 85 5.18.5 IMPACT ON END-USE INDUSTRIES 85 5.18.5.1 Hospitals, ambulatory surgical centers, and nursing homes 86 5.18.5.2 Diagnostic & pathology labs 86 5.18.5.3 Blood banks 86 6 BLOOD COLLECTION DEVICES MARKET, BY PRODUCT 87 6.1 INTRODUCTION 88 6.2 BLOOD COLLECTION TUBES 88 6.2.1 BLOOD COLLECTION TUBES MARKET, BY TYPE 88 6.2.1.1 Plasma/Whole-blood tubes 90 6.2.1.1.1 EDTA tubes 92 6.2.1.1.2 Heparin tubes 94 6.2.1.1.3 Coagulation tubes 96 6.2.1.1.4 Glucose tubes 98 6.2.1.1.5 ESR tubes 100 6.2.1.2 Serum tubes 102 6.2.1.2.1 Need for high-quality serum specimens to fuel market 102 6.2.2 BLOOD COLLECTION TUBES, BY SYSTEM TYPE 104 6.2.2.1 Vacuum tubes 105 6.2.2.1.1 Need to minimize blood exposure to promote growth 105 6.2.2.2 Non-vacuum tubes 106 6.2.2.2.1 Cost constraints to contribute to growth 106 6.3 NEEDLES & SYRINGES 109 6.3.1 RISING ADOPTION OF SAFETY BLOOD COLLECTION SETS TO BOLSTER GROWTH 109 6.4 BLOOD BAGS 111 6.4.1 INCREASING BLOOD DONATIONS WORLDWIDE TO AUGMENT GROWTH 111 6.5 BLOOD COLLECTION SYSTEMS/MONITORS 114 6.5.1 GROWING CONCERNS REGARDING BLOOD SAFETY AND BLOOD SHORTAGE TO PROPEL MARKET 114 6.6 LANCETS 116 6.6.1 HIGH CONVENIENCE AND MINIMAL PAIN TO CONTRIBUTE TO GROWTH 116 7 BLOOD COLLECTION DEVICES MARKET, BY METHOD 120 7.1 INTRODUCTION 121 7.2 MANUAL BLOOD COLLECTION 121 7.2.1 RISING INCLINATION TOWARD SELF-CARE AND INCREASING NUMBER OF DIAGNOSTIC CENTERS TO DRIVE MARKET 121 7.3 AUTOMATED BLOOD COLLECTION 123 7.3.1 INCREASING DEMAND FOR SAFER COLLECTION PROCEDURES AND AVAILABILITY OF ADVANCED BLOOD-COLLECTING PRODUCTS TO AID GROWTH 123 8 BLOOD COLLECTION DEVICES MARKET, BY APPLICATION 126 8.1 INTRODUCTION 127 8.2 DIAGNOSTIC APPLICATIONS 127 8.2.1 RISING INCIDENCE OF INFECTIOUS DISEASES TO SPUR GROWTH 127 8.3 THERAPEUTIC APPLICATIONS 130 8.3.1 RISING PREVALENCE OF HEMATOLOGICAL DISORDERS TO SUPPORT GROWTH 130 9 BLOOD COLLECTION DEVICES MARKET, BY END USER 133 9.1 INTRODUCTION 134 9.2 HOSPITALS, AMBULATORY SURGICAL CENTERS, AND NURSING HOMES 134 9.2.1 INCREASING NUMBER OF SURGICAL PROCEDURES AND HOSPITALS TO FOSTER GROWTH 134 9.3 DIAGNOSTIC & PATHOLOGY LABORATORIES 136 9.3.1 RISING NUMBER OF TEST VOLUMES TO CONTRIBUTE TO GROWTH 136 9.4 BLOOD BANKS 138 9.4.1 INCREASING AWARENESS ABOUT BLOOD DONATION AND USE OF BLOOD FOR TREATING CLINICAL CONDITIONS TO BOOST MARKET 138 9.5 OTHER END USERS 140 10 BLOOD COLLECTION DEVICES MARKET, BY REGION 142 10.1 INTRODUCTION 143 10.2 NORTH AMERICA 143 10.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA 147 10.2.2 US 148 10.2.2.1 High healthcare expenditure and increasing prevalence of cancer to expedite growth 148 10.2.3 CANADA 151 10.2.3.1 Growing volume of surgical procedures to support growth 151 10.3 EUROPE 154 10.3.1 MACROECONOMIC OUTLOOK FOR EUROPE 158 10.3.2 GERMANY 158 10.3.2.1 Increasing healthcare expenditure and new blood tests to aid growth 158   10.3.3 FRANCE 162 10.3.3.1 Growing number of new diagnostic tests and prevalence of cardiovascular diseases to drive market 162 10.3.4 UK 166 10.3.4.1 Increasing prevalence of lifestyle diseases and HIV to spur growth 166 10.3.5 ITALY 169 10.3.5.1 Rising blood donation to contribute to growth 169 10.3.6 SPAIN 172 10.3.6.1 Rise in organ transplants to aid growth 172 10.3.7 REST OF EUROPE 176 10.4 ASIA PACIFIC 180 10.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC 184 10.4.2 JAPAN 184 10.4.2.1 Rapid increase in aging population to accelerate growth 184 10.4.3 CHINA 187 10.4.3.1 Growing demand for blood components to facilitate growth 187 10.4.4 INDIA 190 10.4.4.1 Rise in government initiatives for healthcare infrastructure to accelerate growth 190 10.4.5 AUSTRALIA 193 10.4.5.1 Growing emphasis on improving access to diagnostic and preventive healthcare to fuel market 193 10.4.6 REST OF ASIA PACIFIC 196 10.5 LATIN AMERICA 199 10.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA 202 10.6 MIDDLE EAST & AFRICA 203 10.6.1 PREVALENCE OF INFECTIOUS DISEASES AND GROWING HEALTHCARE INFRASTRUCTURE TO SUPPORT MARKET GROWTH 203 10.6.2 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA 206 11 COMPETITIVE LANDSCAPE 207 11.1 OVERVIEW 207 11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 207 11.2.1 OVERVIEW OF KEY STRATEGIES DEPLOYED BY MAJOR PLAYERS 207 11.3 REVENUE ANALYSIS, 2022–2024 208 11.4 MARKET SHARE ANALYSIS, 2024 209 11.5 COMPANY VALUATION AND FINANCIAL METRICS 211 11.6 BRAND/PRODUCT COMPARISON 212 11.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024 212 11.7.1 STARS 212 11.7.2 EMERGING LEADERS 213 11.7.3 PERVASIVE PLAYERS 213 11.7.4 PARTICIPANTS 213 11.7.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024 214 11.7.5.1 Company footprint 214 11.7.5.2 Region footprint 214 11.7.5.3 Product footprint 215 11.7.5.4 Application footprint 215 11.7.5.5 Method footprint 216 11.8 COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024 216 11.8.1 PROGRESSIVE COMPANIES 216 11.8.2 RESPONSIVE COMPANIES 216 11.8.3 DYNAMIC COMPANIES 217 11.8.4 STARTING BLOCKS 217 11.8.5 COMPETITIVE BENCHMARKING 218 11.8.5.1 Detailed list of key startups/SMEs 218 11.8.5.2 Competitive benchmarking of key startups/SMEs 218 11.9 COMPETITIVE SCENARIO 219 11.9.1 PRODUCT LAUNCHES AND APPROVALS 219 11.9.2 DEALS 220 11.9.3 EXPANSIONS 220 12 COMPANY PROFILES 221 12.1 KEY PLAYERS 221 12.1.1 BECTON, DICKINSON AND COMPANY (BD) 221 12.1.1.1 Business overview 221 12.1.1.2 Products offered 222 12.1.1.3 Recent developments 224 12.1.1.3.1 Product launches and approvals 224 12.1.1.3.2 Expansions 224 12.1.1.3.3 Deals 224 12.1.1.4 MnM view 225 12.1.1.4.1 Key strengths 225 12.1.1.4.2 Strategic choices 225 12.1.1.4.3 Weaknesses and competitive threats 225 12.1.2 TERUMO BCT, INC. 226 12.1.2.1 Business overview 226 12.1.2.2 Products offered 228 12.1.2.3 Recent developments 229 12.1.2.3.1 Deals 229 12.1.2.4 MnM view 229 12.1.2.4.1 Key strengths 229 12.1.2.4.2 Strategic choices 229 12.1.2.4.3 Weaknesses and competitive threats 229   12.1.3 FRESENIUS KABI AG 230 12.1.3.1 Business overview 230 12.1.3.2 Products offered 232 12.1.3.3 Recent developments 232 12.1.3.3.1 Product launches and approvals 232 12.1.3.4 MnM view 232 12.1.3.4.1 Key strengths 232 12.1.3.4.2 Strategic choices 232 12.1.3.4.3 Weaknesses and competitive threats 233 12.1.4 GRIFOLS, S.A. 234 12.1.4.1 Business overview 234 12.1.4.2 Products offered 235 12.1.5 NIPRO CORPORATION 236 12.1.5.1 Business overview 236 12.1.5.2 Products offered 237 12.1.6 SARSTEDT AG & CO. KG 238 12.1.6.1 Business overview 238 12.1.6.2 Products offered 238 12.1.7 MACOPHARMA 239 12.1.7.1 Business overview 239 12.1.7.2 Products offered 239 12.1.8 HAEMONETICS CORPORATION 240 12.1.8.1 Business overview 240 12.1.8.2 Products offered 241 12.1.8.3 Recent developments 242 12.1.8.3.1 Deals 242 12.1.8.3.2 Product launches and approvals 242 12.1.8.3.3 Expansions 242 12.1.9 ICU MEDICAL, INC. 243 12.1.9.1 Business overview 243 12.1.9.2 Products offered 244 12.1.10 CARDINAL HEALTH 245 12.1.10.1 Business overview 245 12.1.10.2 Products offered 246 12.1.11 RETRACTABLE TECHNOLOGIES, INC. 248 12.1.11.1 Business overview 248 12.1.11.2 Products offered 249 12.1.12 GREINER HOLDING AG 250 12.1.12.1 Business overview 250 12.1.12.2 Products offered 251   12.2 OTHER PLAYERS 253 12.2.1 LIUYANG SANLI MEDICAL TECHNOLOGY DEVELOPMENT CO., LTD. 253 12.2.2 FL MEDICAL S.R.L. 254 12.2.3 AB MEDICAL CO., LTD. 255 12.2.4 APTACA SPA 256 12.2.5 JIANGSU MICSAFE MEDICAL TECHNOLOGY CO., LTD. 257 12.2.6 DISERA TIBBI MALZEME LOJISTIK SANAYI VE TICARET A.Ş 257 12.2.7 AJOSHA BIO TEKNIK PVT. LTD. 258 12.2.8 PREQ SYSTEMS 259 12.2.9 CML BIOTECH LTD 259 12.2.10 LMB TECHNOLOGIE GMBH 260 12.2.11 MITRA INDUSTRIES PRIVATE LIMITED 260 12.2.12 NEOMEDIC LIMITED 261 12.2.13 MHC MEDICAL PRODUCTS, LLC 261 13 APPENDIX 262 13.1 DISCUSSION GUIDE 262 13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 266 13.3 CUSTOMIZATION OPTIONS 268 13.4 RELATED REPORTS 268 13.5 AUTHOR DETAILS 269
圖表清單 List of Tables & Figures
TABLE 1 BLOOD COLLECTION DEVICES MARKET: KEY DATA FROM PRIMARY SOURCES 35 TABLE 2 BLOOD COLLECTION DEVICES MARKET: RISK ANALYSIS 43 TABLE 3 AVERAGE SELLING PRICING TREND OF BLOOD COLLECTION TUBES AND LANCETS, 2023–2025 (USD) 60 TABLE 4 AVERAGE SELLING PRICE TREND OF BLOOD COLLECTION DEVICES, BY KEY PLAYER, 2023–2025 (USD) 61 TABLE 5 AVERAGE SELLING PRICE TREND OF BLOOD COLLECTION DEVICES, BY REGION, 2023–2025 (USD) 61 TABLE 6 BLOOD COLLECTION DEVICES MARKET: ROLE OF COMPANIES IN ECOSYSTEM 64 TABLE 7 BLOOD COLLECTION DEVICES MARKET: LIST OF MAJOR PATENTS, 2023–2025 68 TABLE 8 IMPORT DATA FOR HS CODE 901890, BY COUNTRY, 2019–2023 (USD MILLION) 69 TABLE 9 EXPORT DATA FOR HS CODE 901890, BY COUNTRY, 2018–2022 (USD MILLION) 69 TABLE 10 BLOOD COLLECTION DEVICES MARKET: KEY CONFERENCES AND EVENTS, 2025–2026 69 TABLE 11 EUROPE: CLASSIFICATION OF DEVICES 72 TABLE 12 JAPAN: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS 74 TABLE 13 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 76 TABLE 14 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 76 TABLE 15 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 77 TABLE 16 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 78 TABLE 17 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 78 TABLE 18 BLOOD COLLECTION DEVICES MARKET: PORTER’S FIVE FORCES ANALYSIS 79 TABLE 19 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY END USER (%) 80 TABLE 20 KEY BUYING CRITERIA, BY END USER 81 TABLE 21 RECIPROCAL TARIFF RATES ADJUSTED BY US 84 TABLE 22 BLOOD COLLECTION DEVICES MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 88 TABLE 23 BLOOD COLLECTION TUBES MARKET, BY TYPE, 2023–2030 (USD MILLION) 88 TABLE 24 BLOOD COLLECTION TUBES MARKET, BY REGION, 2023–2030 (USD MILLION) 89 TABLE 25 NORTH AMERICA: BLOOD COLLECTION TUBES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 89 TABLE 26 EUROPE: BLOOD COLLECTION TUBES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 89 TABLE 27 ASIA PACIFIC: BLOOD COLLECTION TUBES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 90 TABLE 28 PLASMA/WHOLE-BLOOD TUBES AVAILABLE IN MARKET 90 TABLE 29 BLOOD COLLECTION TUBES MARKET FOR PLASMA/WHOLE-BLOOD COLLECTION TUBES, BY TYPE, 2023–2030 (USD MILLION) 91 TABLE 30 BLOOD COLLECTION TUBES MARKET FOR PLASMA/WHOLE-BLOOD COLLECTION TUBES, BY REGION, 2023–2030 (USD MILLION) 91 TABLE 31 NORTH AMERICA: BLOOD COLLECTION TUBES MARKET FOR PLASMA/WHOLE-BLOOD COLLECTION TUBES, BY COUNTRY, 2023–2030 (USD MILLION) 91 TABLE 32 EUROPE: BLOOD COLLECTION TUBES MARKET FOR PLASMA/WHOLE-BLOOD COLLECTION TUBES, BY COUNTRY, 2023–2030 (USD MILLION) 92 TABLE 33 ASIA PACIFIC: BLOOD COLLECTION TUBES MARKET FOR PLASMA/WHOLE-BLOOD COLLECTION TUBES, BY COUNTRY, 2023–2030 (USD MILLION) 92 TABLE 34 EDTA TUBES AVAILABLE IN MARKET 93 TABLE 35 BLOOD COLLECTION TUBES MARKET FOR EDTA TUBES, BY REGION, 2023–2030 (USD MILLION) 93 TABLE 36 NORTH AMERICA: BLOOD COLLECTION TUBES MARKET FOR EDTA TUBES, BY COUNTRY, 2023–2030 (USD MILLION) 93 TABLE 37 EUROPE: BLOOD COLLECTION TUBES MARKET FOR EDTA TUBES, BY COUNTRY, 2023–2030 (USD MILLION) 94 TABLE 38 ASIA PACIFIC: BLOOD COLLECTION TUBES MARKET FOR EDTA TUBES, BY COUNTRY, 2023–2030 (USD MILLION) 94 TABLE 39 HEPARIN TUBES AVAILABLE IN MARKET 95 TABLE 40 BLOOD COLLECTION TUBES MARKET FOR HEPARIN TUBES, BY REGION, 2023–2030 (USD MILLION) 95 TABLE 41 NORTH AMERICA: BLOOD COLLECTION TUBES MARKET FOR HEPARIN TUBES, BY COUNTRY, 2023–2030 (USD MILLION) 95 TABLE 42 EUROPE: BLOOD COLLECTION TUBES MARKET FOR HEPARIN TUBES, BY COUNTRY, 2023–2030 (USD MILLION) 96 TABLE 43 ASIA PACIFIC: BLOOD COLLECTION TUBES MARKET FOR HEPARIN TUBES, BY COUNTRY, 2023–2030 (USD MILLION) 96 TABLE 44 COAGULATION TUBES AVAILABLE IN MARKET 96 TABLE 45 BLOOD COLLECTION TUBES MARKET FOR COAGULATION TUBES, BY REGION, 2023–2030 (USD MILLION) 97 TABLE 46 NORTH AMERICA: BLOOD COLLECTION TUBES MARKET FOR COAGULATION TUBES, BY COUNTRY, 2023–2030 (USD MILLION) 97 TABLE 47 EUROPE: BLOOD COLLECTION TUBES MARKET FOR COAGULATION TUBES, BY COUNTRY, 2023–2030 (USD MILLION) 98 TABLE 48 ASIA PACIFIC: BLOOD COLLECTION TUBES MARKET FOR COAGULATION TUBES, BY COUNTRY, 2023–2030 (USD MILLION) 98 TABLE 49 GLUCOSE TUBES AVAILABLE IN MARKET 99 TABLE 50 BLOOD COLLECTION TUBES MARKET FOR GLUCOSE TUBES, BY REGION, 2023–2030 (USD MILLION) 99 TABLE 51 NORTH AMERICA: BLOOD COLLECTION TUBES MARKET FOR GLUCOSE TUBES, BY COUNTRY, 2023–2030 (USD MILLION) 99 TABLE 52 EUROPE: BLOOD COLLECTION TUBES MARKET FOR GLUCOSE TUBES, BY COUNTRY, 2023–2030 (USD MILLION) 100 TABLE 53 ASIA PACIFIC: BLOOD COLLECTION TUBES MARKET FOR GLUCOSE TUBES, BY COUNTRY, 2023–2030 (USD MILLION) 100 TABLE 54 ESR TUBES AVAILABLE IN MARKET 101 TABLE 55 BLOOD COLLECTION TUBES MARKET FOR ESR TUBES, BY REGION, 2023–2030 (USD MILLION) 101 TABLE 56 NORTH AMERICA: BLOOD COLLECTION TUBES MARKET FOR ESR TUBES, BY COUNTRY, 2023–2030 (USD MILLION) 101 TABLE 57 EUROPE: BLOOD COLLECTION TUBES MARKET FOR ESR TUBES, BY COUNTRY, 2023–2030 (USD MILLION) 102 TABLE 58 ASIA PACIFIC: BLOOD COLLECTION TUBES MARKET FOR ESR TUBES, BY COUNTRY, 2023–2030 (USD MILLION) 102 TABLE 59 SERUM TUBES AVAILABLE IN MARKET 103 TABLE 60 BLOOD COLLECTION TUBES MARKET FOR SERUM TUBES, BY REGION, 2023–2030 (USD MILLION) 103 TABLE 61 NORTH AMERICA: BLOOD COLLECTION TUBES MARKET FOR SERUM TUBES, BY COUNTRY, 2023–2030 (USD MILLION) 103 TABLE 62 EUROPE: BLOOD COLLECTION TUBES MARKET FOR SERUM TUBES, BY COUNTRY, 2023–2030 (USD MILLION) 104 TABLE 63 ASIA PACIFIC: BLOOD COLLECTION TUBES MARKET FOR SERUM TUBES, BY COUNTRY, 2023–2030 (USD MILLION) 104 TABLE 64 BLOOD COLLECTION TUBES MARKET, BY SYSTEM TYPE, 2023–2030 (USD MILLION) 104 TABLE 65 VACUUM TUBES AVAILABLE IN MARKET 105 TABLE 66 BLOOD COLLECTION TUBES MARKET FOR VACUUM TUBES, BY REGION, 2023–2030 (USD MILLION) 105 TABLE 67 NORTH AMERICA: BLOOD COLLECTION TUBES MARKET FOR VACUUM TUBES, BY COUNTRY, 2023–2030 (USD MILLION) 105 TABLE 68 EUROPE: BLOOD COLLECTION TUBES MARKET FOR VACUUM TUBES, BY COUNTRY, 2023–2030 (USD MILLION) 106 TABLE 69 ASIA PACIFIC: BLOOD COLLECTION TUBES MARKET FOR VACUUM TUBES, BY COUNTRY, 2023–2030 (USD MILLION) 106 TABLE 70 NON-VACUUM TUBES AVAILABLE IN MARKET 107 TABLE 71 BLOOD COLLECTION TUBES MARKET FOR NON-VACUUM TUBES, BY REGION, 2023–2030 (USD MILLION) 107 TABLE 72 NORTH AMERICA: BLOOD COLLECTION TUBES MARKET FOR NON-VACUUM TUBES, BY COUNTRY, 2023–2030 (USD MILLION) 108 TABLE 73 EUROPE: BLOOD COLLECTION TUBES MARKET FOR NON-VACUUM TUBES, BY COUNTRY, 2023–2030 (USD MILLION) 108 TABLE 74 ASIA PACIFIC: BLOOD COLLECTION TUBES MARKET FOR NON-VACUUM TUBES, BY COUNTRY, 2023–2030 (USD MILLION) 108 TABLE 75 NEEDLES & SYRINGES AVAILABLE IN MARKET 109 TABLE 76 BLOOD COLLECTION DEVICES MARKET FOR NEEDLES & SYRINGES, BY REGION, 2023–2030 (USD MILLION) 110 TABLE 77 NORTH AMERICA: BLOOD COLLECTION DEVICES MARKET FOR NEEDLES & SYRINGES, BY COUNTRY, 2023–2030 (USD MILLION) 110 TABLE 78 EUROPE: BLOOD COLLECTION DEVICES MARKET FOR NEEDLES & SYRINGES, BY COUNTRY, 2023–2030 (USD MILLION) 110 TABLE 79 ASIA PACIFIC: BLOOD COLLECTION DEVICES MARKET FOR NEEDLES & SYRINGES, BY COUNTRY, 2023–2030 (USD MILLION) 111 TABLE 80 BLOOD BAGS AVAILABLE IN MARKET 111 TABLE 81 BLOOD COLLECTION DEVICES MARKET FOR BLOOD BAGS, BY REGION, 2023–2030 (USD MILLION) 112 TABLE 82 NORTH AMERICA: BLOOD COLLECTION DEVICES MARKET FOR BLOOD BAGS, BY COUNTRY, 2023–2030 (USD MILLION) 113 TABLE 83 EUROPE: BLOOD COLLECTION DEVICES MARKET FOR BLOOD BAGS, BY COUNTRY, 2023–2030 (USD MILLION) 113 TABLE 84 ASIA PACIFIC: BLOOD COLLECTION DEVICES MARKET FOR BLOOD BAGS, BY COUNTRY, 2023–2030 (USD MILLION) 113 TABLE 85 BLOOD COLLECTION SYSTEMS/MONITORS AVAILABLE IN MARKET 114 TABLE 86 BLOOD COLLECTION DEVICES MARKET FOR BLOOD COLLECTION SYSTEMS/MONITORS, BY REGION, 2023–2030 (USD MILLION) 115 TABLE 87 NORTH AMERICA: BLOOD COLLECTION DEVICES MARKET FOR BLOOD COLLECTION SYSTEMS/MONITORS, BY COUNTRY, 2023–2030 (USD MILLION) 115 TABLE 88 EUROPE: BLOOD COLLECTION DEVICES MARKET FOR BLOOD COLLECTION SYSTEMS/MONITORS, BY COUNTRY, 2023–2030 (USD MILLION) 116 TABLE 89 ASIA PACIFIC: BLOOD COLLECTION DEVICES MARKET FOR BLOOD COLLECTION SYSTEMS/MONITORS, BY COUNTRY, 2023–2030 (USD MILLION) 116 TABLE 90 LANCETS AVAILABLE IN MARKET 117 TABLE 91 BLOOD COLLECTION DEVICES MARKET FOR LANCETS, BY REGION, 2023–2030 (USD MILLION) 117 TABLE 92 NORTH AMERICA: BLOOD COLLECTION DEVICES MARKET FOR LANCETS, BY COUNTRY, 2023–2030 (USD MILLION) 118 TABLE 93 EUROPE: BLOOD COLLECTION DEVICES MARKET FOR LANCETS, BY COUNTRY, 2023–2030 (USD MILLION) 118 TABLE 94 ASIA PACIFIC: BLOOD COLLECTION DEVICES MARKET FOR LANCETS, BY COUNTRY, 2023–2030 (USD MILLION) 118 TABLE 95 GLOBAL NUMBER OF LANCETS MANUFACTURED, 2023–2030 (UNITS) 119 TABLE 96 BLOOD COLLECTION DEVICES MARKET, BY METHOD, 2023–2030 (USD MILLION) 121 TABLE 97 BLOOD COLLECTION DEVICES MARKET FOR MANUAL BLOOD COLLECTION, BY REGION, 2023–2030 (USD MILLION) 122 TABLE 98 NORTH AMERICA: BLOOD COLLECTION DEVICES MARKET FOR MANUAL BLOOD COLLECTION, BY COUNTRY, 2023–2030 (USD MILLION) 122 TABLE 99 EUROPE: BLOOD COLLECTION DEVICES MARKET FOR MANUAL BLOOD COLLECTION, BY COUNTRY, 2023–2030 (USD MILLION) 123 TABLE 100 ASIA PACIFIC: BLOOD COLLECTION DEVICES MARKET FOR MANUAL BLOOD COLLECTION, BY COUNTRY, 2023–2030 (USD MILLION) 123 TABLE 101 BLOOD COLLECTION DEVICES MARKET FOR AUTOMATED BLOOD COLLECTION, BY REGION, 2023–2030 (USD MILLION) 124 TABLE 102 NORTH AMERICA: BLOOD COLLECTION DEVICES MARKET FOR AUTOMATED BLOOD COLLECTION, BY COUNTRY, 2023–2030 (USD MILLION) 124 TABLE 103 EUROPE: BLOOD COLLECTION DEVICES MARKET FOR AUTOMATED BLOOD COLLECTION, BY COUNTRY, 2023–2030 (USD MILLION) 124 TABLE 104 ASIA PACIFIC: BLOOD COLLECTION DEVICES MARKET FOR AUTOMATED BLOOD COLLECTION, BY COUNTRY, 2023–2030 (USD MILLION) 125 TABLE 105 BLOOD COLLECTION DEVICES MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 127 TABLE 106 REGIONAL HIV DATA, 2024 127 TABLE 107 BLOOD COLLECTION DEVICES MARKET FOR DIAGNOSTIC APPLICATIONS, BY REGION, 2023–2030 (USD MILLION) 129 TABLE 108 NORTH AMERICA: BLOOD COLLECTION DEVICES MARKET FOR DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION) 129 TABLE 109 EUROPE: BLOOD COLLECTION DEVICES MARKET FOR DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION) 129 TABLE 110 ASIA PACIFIC: BLOOD COLLECTION DEVICES MARKET FOR DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION) 130 TABLE 111 BLOOD COLLECTION DEVICES MARKET FOR THERAPEUTIC APPLICATIONS, BY REGION, 2023–2030 (USD MILLION) 131 TABLE 112 NORTH AMERICA: BLOOD COLLECTION DEVICES MARKET FOR THERAPEUTIC APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION) 131 TABLE 113 EUROPE: BLOOD COLLECTION DEVICES MARKET FOR THERAPEUTIC APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION) 131 TABLE 114 ASIA PACIFIC: BLOOD COLLECTION DEVICES MARKET FOR THERAPEUTIC APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION) 132 TABLE 115 BLOOD COLLECTION DEVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 134 TABLE 116 BLOOD COLLECTION DEVICES MARKET FOR HOSPITALS, AMBULATORY SURGICAL CENTERS, AND NURSING HOMES, BY REGION, 2023–2030 (USD MILLION) 135 TABLE 117 NORTH AMERICA: BLOOD COLLECTION DEVICES MARKET FOR HOSPITALS, AMBULATORY SURGICAL CENTERS, AND NURSING HOMES, BY COUNTRY, 2023–2030 (USD MILLION) 135 TABLE 118 EUROPE: BLOOD COLLECTION DEVICES MARKET FOR HOSPITALS, AMBULATORY SURGICAL CENTERS, AND NURSING HOMES, BY COUNTRY, 2023–2030 (USD MILLION) 136 TABLE 119 ASIA PACIFIC: BLOOD COLLECTION DEVICES MARKET FOR HOSPITALS, AMBULATORY SURGICAL CENTERS, AND NURSING HOMES, BY COUNTRY, 2023–2030 (USD MILLION) 136 TABLE 120 BLOOD COLLECTION DEVICES MARKET FOR DIAGNOSTIC & PATHOLOGY LABORATORIES, BY REGION, 2023–2030 (USD MILLION) 137 TABLE 121 NORTH AMERICA: BLOOD COLLECTION DEVICES MARKET FOR DIAGNOSTIC & PATHOLOGY LABORATORIES, BY COUNTRY, 2023–2030 (USD MILLION) 137 TABLE 122 EUROPE: BLOOD COLLECTION DEVICES MARKET FOR DIAGNOSTIC & PATHOLOGY LABORATORIES, BY COUNTRY, 2023–2030 (USD MILLION) 137 TABLE 123 ASIA PACIFIC: BLOOD COLLECTION DEVICES MARKET FOR DIAGNOSTIC & PATHOLOGY LABORATORIES, BY COUNTRY, 2023–2030 (USD MILLION) 138 TABLE 124 BLOOD COLLECTION DEVICES MARKET FOR BLOOD BANKS, BY REGION, 2023–2030 (USD MILLION) 139 TABLE 125 NORTH AMERICA: BLOOD COLLECTION DEVICES MARKET FOR BLOOD BANKS, BY COUNTRY, 2023–2030 (USD MILLION) 139 TABLE 126 EUROPE: BLOOD COLLECTION DEVICES MARKET FOR BLOOD BANKS, BY COUNTRY, 2023–2030 (USD MILLION) 139 TABLE 127 ASIA PACIFIC: BLOOD COLLECTION DEVICES MARKET FOR BLOOD BANKS, BY COUNTRY, 2023–2030 (USD MILLION) 140 TABLE 128 BLOOD COLLECTION DEVICES MARKET FOR OTHER END USERS, BY REGION, 2023–2030 (USD MILLION) 140 TABLE 129 NORTH AMERICA: BLOOD COLLECTION DEVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2023–2030 (USD MILLION) 141 TABLE 130 EUROPE: BLOOD COLLECTION DEVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2023–2030 (USD MILLION) 141 TABLE 131 ASIA PACIFIC: BLOOD COLLECTION DEVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2023–2030 (USD MILLION) 141 TABLE 132 BLOOD COLLECTION DEVICES MARKET, BY REGION, 2023–2030 (USD MILLION) 143 TABLE 133 NORTH AMERICA: MACROECONOMIC INDICATORS 144 TABLE 134 NORTH AMERICA: BLOOD COLLECTION DEVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 145 TABLE 135 NORTH AMERICA: BLOOD COLLECTION DEVICES MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 145 TABLE 136 NORTH AMERICA: BLOOD COLLECTION TUBES MARKET, BY TYPE, 2023–2030 (USD MILLION) 145 TABLE 137 NORTH AMERICA: BLOOD COLLECTION TUBES MARKET FOR PLASMA/WHOLE-BLOOD COLLECTION TUBES, BY TYPE, 2023–2030 (USD MILLION) 146 TABLE 138 NORTH AMERICA: BLOOD COLLECTION TUBES MARKET, BY SYSTEM TYPE, 2023–2030 (USD MILLION) 146 TABLE 139 NORTH AMERICA: BLOOD COLLECTION DEVICES MARKET, BY METHOD, 2023–2030 (USD MILLION) 146 TABLE 140 NORTH AMERICA: BLOOD COLLECTION DEVICES MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 147 TABLE 141 NORTH AMERICA: BLOOD COLLECTION DEVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 147 TABLE 142 US: BLOOD COLLECTION DEVICES MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 149 TABLE 143 US: BLOOD COLLECTION TUBES MARKET, BY TYPE, 2023–2030 (USD MILLION) 150 TABLE 144 US: BLOOD COLLECTION TUBES MARKET FOR PLASMA/WHOLE-BLOOD COLLECTION TUBES, BY TYPE, 2023–2030 (USD MILLION) 150 TABLE 145 US: BLOOD COLLECTION TUBES MARKET, BY SYSTEM TYPE, 2023–2030 (USD MILLION) 150 TABLE 146 US: BLOOD COLLECTION DEVICES MARKET, BY METHOD, 2023–2030 (USD MILLION) 151 TABLE 147 US: BLOOD COLLECTION DEVICES MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 151 TABLE 148 US: BLOOD COLLECTION DEVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 151 TABLE 149 SURGICAL PROCEDURES PERFORMED IN CANADA, 2024 152 TABLE 150 CANADA: BLOOD COLLECTION DEVICES MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 152 TABLE 151 CANADA: BLOOD COLLECTION TUBES MARKET, BY TYPE, 2023–2030 (USD MILLION) 153 TABLE 152 CANADA: BLOOD COLLECTION TUBES MARKET FOR PLASMA/WHOLE-BLOOD COLLECTION TUBES, BY TYPE, 2023–2030 (USD MILLION) 153 TABLE 153 CANADA: BLOOD COLLECTION TUBES MARKET, BY SYSTEM TYPE, 2023–2030 (USD MILLION) 153 TABLE 154 CANADA: BLOOD COLLECTION DEVICES MARKET, BY METHOD, 2023–2030 (USD MILLION) 154 TABLE 155 CANADA: BLOOD COLLECTION DEVICES MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 154 TABLE 156 CANADA: BLOOD COLLECTION DEVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 154 TABLE 157 EUROPE: BLOOD COLLECTION DEVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 155 TABLE 158 EUROPE: BLOOD COLLECTION DEVICES MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 156 TABLE 159 EUROPE: BLOOD COLLECTION TUBES MARKET, BY TYPE, 2023–2030 (USD MILLION) 156 TABLE 160 EUROPE: BLOOD COLLECTION TUBES MARKET FOR PLASMA/WHOLE-BLOOD COLLECTION TUBES, BY TYPE, 2023–2030 (USD MILLION) 156 TABLE 161 EUROPE: BLOOD COLLECTION TUBES MARKET, BY SYSTEM TYPE, 2023–2030 (USD MILLION) 157 TABLE 162 EUROPE: BLOOD COLLECTION DEVICES MARKET, BY METHOD, 2023–2030 (USD MILLION) 157 TABLE 163 EUROPE: BLOOD COLLECTION DEVICES MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 157 TABLE 164 EUROPE: BLOOD COLLECTION DEVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 158 TABLE 165 SURGICAL PROCEDURES PERFORMED IN GERMANY, 2024 159 TABLE 166 GERMANY: KEY MACROECONOMIC INDICATORS 159 TABLE 167 GERMANY: BLOOD COLLECTION DEVICES MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 160 TABLE 168 GERMANY: BLOOD COLLECTION TUBES MARKET, BY TYPE, 2023–2030 (USD MILLION) 160 TABLE 169 GERMANY: BLOOD COLLECTION TUBES MARKET FOR PLASMA/WHOLE-BLOOD COLLECTION TUBES, BY TYPE, 2023–2030 (USD MILLION) 160 TABLE 170 GERMANY: BLOOD COLLECTION TUBES MARKET, BY SYSTEM TYPE, 2023–2030 (USD MILLION) 161 TABLE 171 GERMANY: BLOOD COLLECTION DEVICES MARKET, BY METHOD, 2023–2030 (USD MILLION) 161 TABLE 172 GERMANY: BLOOD COLLECTION DEVICES MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 161 TABLE 173 GERMANY: BLOOD COLLECTION DEVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 162 TABLE 174 SURGICAL PROCEDURES PERFORMED IN FRANCE, 2024 163 TABLE 175 FRANCE: KEY MACROECONOMIC INDICATORS 163 TABLE 176 FRANCE: BLOOD COLLECTION DEVICES MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 163 TABLE 177 FRANCE: BLOOD COLLECTION TUBES MARKET, BY TYPE, 2023–2030 (USD MILLION) 164 TABLE 178 FRANCE: BLOOD COLLECTION TUBES MARKET FOR PLASMA/WHOLE-BLOOD COLLECTION TUBES, BY TYPE, 2023–2030 (USD MILLION) 164 TABLE 179 FRANCE: BLOOD COLLECTION TUBES MARKET, BY SYSTEM TYPE, 2023–2030 (USD MILLION) 164 TABLE 180 FRANCE: BLOOD COLLECTION DEVICES MARKET, BY METHOD, 2023–2030 (USD MILLION) 165 TABLE 181 FRANCE: BLOOD COLLECTION DEVICES MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 165 TABLE 182 FRANCE: BLOOD COLLECTION DEVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 165 TABLE 183 SURGICAL PROCEDURES PERFORMED IN UK, 2024 166 TABLE 184 UK: KEY MACROECONOMIC INDICATORS 167 TABLE 185 UK: BLOOD COLLECTION DEVICES MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 167 TABLE 186 UK: BLOOD COLLECTION TUBES MARKET, BY TYPE, 2023–2030 (USD MILLION) 167 TABLE 187 UK: BLOOD COLLECTION TUBES MARKET FOR PLASMA/WHOLE-BLOOD COLLECTION TUBES, BY TYPE, 2023–2030 (USD MILLION) 168 TABLE 188 UK: BLOOD COLLECTION TUBES MARKET, BY SYSTEM TYPE, 2023–2030 (USD MILLION) 168 TABLE 189 UK: BLOOD COLLECTION DEVICES MARKET, BY METHOD, 2023–2030 (USD MILLION) 168 TABLE 190 UK: BLOOD COLLECTION DEVICES MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 169 TABLE 191 UK: BLOOD COLLECTION DEVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 169 TABLE 192 SURGICAL PROCEDURES PERFORMED IN ITALY, 2024 170 TABLE 193 ITALY: KEY MACROECONOMIC INDICATORS 170 TABLE 194 ITALY: BLOOD COLLECTION DEVICES MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 170 TABLE 195 ITALY: BLOOD COLLECTION TUBES MARKET, BY TYPE, 2023–2030 (USD MILLION) 171 TABLE 196 ITALY: BLOOD COLLECTION TUBES MARKET FOR PLASMA/WHOLE-BLOOD COLLECTION TUBES, BY TYPE, 2023–2030 (USD MILLION) 171 TABLE 197 ITALY: BLOOD COLLECTION TUBES MARKET, BY SYSTEM TYPE, 2023–2030 (USD MILLION) 171 TABLE 198 ITALY: BLOOD COLLECTION DEVICES MARKET, BY METHOD, 2023–2030 (USD MILLION) 172 TABLE 199 ITALY: BLOOD COLLECTION DEVICES MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 172 TABLE 200 ITALY: BLOOD COLLECTION DEVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 172 TABLE 201 SURGICAL PROCEDURES PERFORMED IN SPAIN, 2024 173 TABLE 202 SPAIN: KEY MACROECONOMIC INDICATORS 173 TABLE 203 SPAIN: BLOOD COLLECTION DEVICES MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 174 TABLE 204 SPAIN: BLOOD COLLECTION TUBES MARKET, BY TYPE, 2023–2030 (USD MILLION) 174 TABLE 205 SPAIN: BLOOD COLLECTION TUBES MARKET FOR PLASMA/WHOLE-BLOOD COLLECTION TUBES, BY TYPE, 2023–2030 (USD MILLION) 174 TABLE 206 SPAIN: BLOOD COLLECTION TUBES MARKET, BY SYSTEM TYPE, 2023–2030 (USD MILLION) 175 TABLE 207 SPAIN: BLOOD COLLECTION DEVICES MARKET, BY METHOD, 2023–2030 (USD MILLION) 175 TABLE 208 SPAIN: BLOOD COLLECTION DEVICES MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 175 TABLE 209 SPAIN: BLOOD COLLECTION DEVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 176 TABLE 210 REST OF EUROPE: HEALTHCARE EXPENDITURE, BY COUNTRY, 2020 VS. 2024 (% OF GDP) 176 TABLE 211 PERCENTAGE OF POPULATION AGED 60 YEARS OR OVER, 2017 VS. 2050 177 TABLE 212 SURGICAL PROCEDURES PERFORMED IN SWITZERLAND, 2024 177 TABLE 213 REST OF EUROPE: BLOOD COLLECTION DEVICES MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 178 TABLE 214 REST OF EUROPE: BLOOD COLLECTION TUBES MARKET, BY TYPE, 2023–2030 (USD MILLION) 178 TABLE 215 REST OF EUROPE: BLOOD COLLECTION TUBES MARKET FOR PLASMA/WHOLE-BLOOD COLLECTION TUBES, BY TYPE, 2023–2030 (USD MILLION) 178 TABLE 216 REST OF EUROPE: BLOOD COLLECTION TUBES MARKET, BY SYSTEM TYPE, 2023–2030 (USD MILLION) 179 TABLE 217 REST OF EUROPE: BLOOD COLLECTION DEVICES MARKET, BY METHOD, 2023–2030 (USD MILLION) 179 TABLE 218 REST OF EUROPE: BLOOD COLLECTION DEVICES MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 179 TABLE 219 REST OF EUROPE: BLOOD COLLECTION DEVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 180 TABLE 220 ASIA PACIFIC: BLOOD COLLECTION DEVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 181 TABLE 221 ASIA PACIFIC: BLOOD COLLECTION DEVICES MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 182 TABLE 222 ASIA PACIFIC: BLOOD COLLECTION TUBES MARKET, BY TYPE, 2023–2030 (USD MILLION) 182 TABLE 223 ASIA PACIFIC: BLOOD COLLECTION TUBES MARKET FOR PLASMA/WHOLE-BLOOD COLLECTION TUBES, BY TYPE, 2023–2030 (USD MILLION) 182 TABLE 224 ASIA PACIFIC: BLOOD COLLECTION TUBES MARKET, BY SYSTEM TYPE, 2023–2030 (USD MILLION) 183 TABLE 225 ASIA PACIFIC: BLOOD COLLECTION DEVICES MARKET, BY METHOD, 2023–2030 (USD MILLION) 183 TABLE 226 ASIA PACIFIC: BLOOD COLLECTION DEVICES MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 183 TABLE 227 ASIA PACIFIC: BLOOD COLLECTION DEVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 184 TABLE 228 JAPAN: KEY MACROECONOMIC INDICATORS 185 TABLE 229 JAPAN: BLOOD COLLECTION DEVICES MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 185 TABLE 230 JAPAN: BLOOD COLLECTION TUBES MARKET, BY TYPE, 2023–2030 (USD MILLION) 185 TABLE 231 JAPAN: BLOOD COLLECTION TUBES MARKET FOR PLASMA/WHOLE-BLOOD COLLECTION TUBES, BY TYPE, 2023–2030 (USD MILLION) 186 TABLE 232 JAPAN: BLOOD COLLECTION TUBES MARKET, BY SYSTEM TYPE, 2023–2030 (USD MILLION) 186 TABLE 233 JAPAN: BLOOD COLLECTION DEVICES MARKET, BY METHOD, 2023–2030 (USD MILLION) 186 TABLE 234 JAPAN: BLOOD COLLECTION DEVICES MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 187 TABLE 235 JAPAN: BLOOD COLLECTION DEVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 187 TABLE 236 CHINA: KEY MACROECONOMIC INDICATORS 188 TABLE 237 CHINA: BLOOD COLLECTION DEVICES MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 188 TABLE 238 CHINA: BLOOD COLLECTION TUBES MARKET, BY TYPE, 2023–2030 (USD MILLION) 188 TABLE 239 CHINA: BLOOD COLLECTION TUBES MARKET FOR PLASMA/WHOLE-BLOOD COLLECTION TUBES, BY TYPE, 2023–2030 (USD MILLION) 189 TABLE 240 CHINA: BLOOD COLLECTION TUBES MARKET, BY SYSTEM TYPE, 2023–2030 (USD MILLION) 189 TABLE 241 CHINA: BLOOD COLLECTION DEVICES MARKET, BY METHOD, 2023–2030 (USD MILLION) 189 TABLE 242 CHINA: BLOOD COLLECTION DEVICES MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 190 TABLE 243 CHINA: BLOOD COLLECTION DEVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 190 TABLE 244 INDIA: KEY MACROECONOMIC INDICATORS 191 TABLE 245 INDIA: BLOOD COLLECTION DEVICES MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 191 TABLE 246 INDIA: BLOOD COLLECTION TUBES MARKET, BY TYPE, 2023–2030 (USD MILLION) 192 TABLE 247 INDIA: BLOOD COLLECTION TUBES MARKET FOR PLASMA/WHOLE-BLOOD COLLECTION TUBES, BY TYPE, 2023–2030 (USD MILLION) 192 TABLE 248 INDIA: BLOOD COLLECTION TUBES MARKET, BY SYSTEM TYPE, 2023–2030 (USD MILLION) 192 TABLE 249 INDIA: BLOOD COLLECTION DEVICES MARKET, BY METHOD, 2023–2030 (USD MILLION) 193 TABLE 250 INDIA: BLOOD COLLECTION DEVICES MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 193 TABLE 251 INDIA: BLOOD COLLECTION DEVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 193 TABLE 252 AUSTRALIA: BLOOD COLLECTION DEVICES MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 194 TABLE 253 AUSTRALIA: BLOOD COLLECTION TUBES MARKET, BY TYPE, 2023–2030 (USD MILLION) 194 TABLE 254 AUSTRALIA: BLOOD COLLECTION TUBES MARKET FOR PLASMA/WHOLE-BLOOD COLLECTION TUBES, BY TYPE, 2023–2030 (USD MILLION) 195 TABLE 255 AUSTRALIA: BLOOD COLLECTION TUBES MARKET, BY SYSTEM TYPE, 2023–2030 (USD MILLION) 195 TABLE 256 AUSTRALIA: BLOOD COLLECTION DEVICES MARKET, BY METHOD, 2023–2030 (USD MILLION) 195 TABLE 257 AUSTRALIA: BLOOD COLLECTION DEVICES MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 196 TABLE 258 AUSTRALIA: BLOOD COLLECTION DEVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 196 TABLE 259 SURGICAL PROCEDURES IN SOUTH KOREA, 2024 197 TABLE 260 REST OF ASIA PACIFIC: BLOOD COLLECTION DEVICES MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 197 TABLE 261 REST OF ASIA PACIFIC: BLOOD COLLECTION TUBES MARKET, BY TYPE, 2023–2030 (USD MILLION) 198 TABLE 262 REST OF ASIA PACIFIC: BLOOD COLLECTION TUBES MARKET FOR PLASMA/WHOLE-BLOOD COLLECTION TUBES, BY TYPE, 2023–2030 (USD MILLION) 198 TABLE 263 REST OF ASIA PACIFIC: BLOOD COLLECTION TUBES MARKET, BY SYSTEM TYPE, 2023–2030 (USD MILLION) 198 TABLE 264 REST OF ASIA PACIFIC: BLOOD COLLECTION DEVICES MARKET, BY METHOD, 2023–2030 (USD MILLION) 199 TABLE 265 REST OF ASIA PACIFIC: BLOOD COLLECTION DEVICES MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 199 TABLE 266 REST OF ASIA PACIFIC: BLOOD COLLECTION DEVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 199 TABLE 267 LATIN AMERICA: KEY MACROECONOMIC INDICATORS 200 TABLE 268 LATIN AMERICA: BLOOD COLLECTION DEVICES MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 200 TABLE 269 LATIN AMERICA: BLOOD COLLECTION TUBES MARKET, BY TYPE, 2023–2030 (USD MILLION) 200 TABLE 270 LATIN AMERICA: BLOOD COLLECTION TUBES MARKET FOR PLASMA/WHOLE-BLOOD COLLECTION TUBES, BY TYPE, 2023–2030 (USD MILLION) 201 TABLE 271 LATIN AMERICA: BLOOD COLLECTION TUBES MARKET, BY SYSTEM TYPE, 2023–2030 (USD MILLION) 201 TABLE 272 LATIN AMERICA: BLOOD COLLECTION DEVICES MARKET, BY METHOD, 2023–2030 (USD MILLION) 201 TABLE 273 LATIN AMERICA: BLOOD COLLECTION DEVICES MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 202 TABLE 274 LATIN AMERICA: BLOOD COLLECTION DEVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 202 TABLE 275 MIDDLE EAST & AFRICA: KEY MACROECONOMIC INDICATORS 204 TABLE 276 MIDDLE EAST & AFRICA: BLOOD COLLECTION DEVICES MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 204 TABLE 277 MIDDLE EAST & AFRICA: BLOOD COLLECTION TUBES MARKET, BY TYPE, 2023–2030 (USD MILLION) 204 TABLE 278 MIDDLE EAST & AFRICA: BLOOD COLLECTION TUBES MARKET FOR PLASMA/WHOLE-BLOOD COLLECTION TUBES, BY TYPE, 2023–2030 (USD MILLION) 205 TABLE 279 MIDDLE EAST & AFRICA: BLOOD COLLECTION TUBES MARKET, BY SYSTEM TYPE, 2023–2030 (USD MILLION) 205 TABLE 280 MIDDLE EAST & AFRICA: BLOOD COLLECTION DEVICES MARKET, BY METHOD, 2023–2030 (USD MILLION) 205 TABLE 281 MIDDLE EAST & AFRICA: BLOOD COLLECTION DEVICES MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 206 TABLE 282 MIDDLE EAST & AFRICA: BLOOD COLLECTION DEVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 206 TABLE 283 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN BLOOD COLLECTION DEVICES MARKET, JANUARY 2022−JUNE 2025 207 TABLE 284 BLOOD COLLECTION DEVICES MARKET: DEGREE OF COMPETITION 210 TABLE 285 BLOOD COLLECTION DEVICES MARKET: REGION FOOTPRINT 214 TABLE 286 BLOOD COLLECTION DEVICES MARKET: PRODUCT FOOTPRINT 215 TABLE 287 BLOOD COLLECTION DEVICES MARKET: APPLICATION FOOTPRINT 215 TABLE 288 BLOOD COLLECTION DEVICES MARKET: METHOD FOOTPRINT 216 TABLE 289 BLOOD COLLECTION DEVICES MARKET: DETAILED LIST OF KEY STARTUPS/SMES 218 TABLE 290 BLOOD COLLECTION DEVICES MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES, BY PRODUCT AND METHOD 218 TABLE 291 BLOOD COLLECTION DEVICES MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES, BY REGION 219 TABLE 292 BLOOD COLLECTION DEVICES MARKET: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2022–JULY 2025 219 TABLE 293 BLOOD COLLECTION DEVICES MARKET: DEALS, JANUARY 2022–JULY 2025 220 TABLE 294 BLOOD COLLECTION DEVICES MARKET: EXPANSIONS, JANUARY 2022–JULY 2025 220 TABLE 295 BECTON, DICKINSON AND COMPANY (BD): COMPANY OVERVIEW 221 TABLE 296 BECTON, DICKINSON AND COMPANY (BD): PRODUCTS OFFERED 222 TABLE 297 BECTON, DICKINSON AND COMPANY (BD): PRODUCT LAUNCHES AND APPROVALS, JANUARY 2022–JULY 2025 224 TABLE 298 BECTON, DICKINSON AND COMPANY (BD): EXPANSIONS, JANUARY 2022–JULY 2025 224 TABLE 299 BECTON, DICKINSON AND COMPANY (BD): DEALS, JANUARY 2022–JULY 2025 224 TABLE 300 TERUMO BCT, INC.: COMPANY OVERVIEW 226 TABLE 301 EXCHANGE RATES USED FOR CONVERSION OF YEN TO USD, 2022–2024 227 TABLE 302 TERUMO BCT, INC.: PRODUCTS OFFERED 228 TABLE 303 TERUMO BCT, INC.: DEALS, JANUARY 2022–JULY 2025 229 TABLE 304 FRESENIUS KABI AG: COMPANY OVERVIEW 230 TABLE 305 EXCHANGE RATES USED FOR CONVERSION OF EURO TO USD, 2022–2024 231 TABLE 306 FRESENIUS KABI AG: PRODUCTS OFFERED 232 TABLE 307 FRESENIUS KABI AG: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2022–JULY 2025 232 TABLE 308 GRIFOLS, S.A.: COMPANY OVERVIEW 234 TABLE 309 GRIFOLS, S.A.: PRODUCTS OFFERED 235 TABLE 310 NIPRO CORPORATION: BUSINESS OVERVIEW 236 TABLE 311 NIPRO CORPORATION: PRODUCTS OFFERED 237 TABLE 312 SARSTEDT AG & CO. KG: COMPANY OVERVIEW 238 TABLE 313 SARSTEDT AG & CO. KG: PRODUCTS OFFERED 238 TABLE 314 MACOPHARMA: COMPANY OVERVIEW 239 TABLE 315 MACOPHARMA: PRODUCTS OFFERED 239 TABLE 316 HAEMONETICS CORPORATION: COMPANY OVERVIEW 240 TABLE 317 HAEMONETICS CORPORATION: PRODUCTS OFFERED 241 TABLE 318 HAEMONETICS CORPORATION: DEALS, JANUARY 2022–JULY 2025 242 TABLE 319 HAEMONETICS CORPORATION: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2022–JULY 2025 242 TABLE 320 HAEMONETICS CORPORATION: EXPANSIONS, JANUARY 2022–JULY 2025 242 TABLE 321 ICU MEDICAL, INC.: COMPANY OVERVIEW 243 TABLE 322 ICU MEDICAL, INC.: PRODUCTS OFFERED 244 TABLE 323 CARDINAL HEALTH: COMPANY OVERVIEW 245 TABLE 324 CARDINAL HEALTH: PRODUCTS OFFERED 246 TABLE 325 RETRACTABLE TECHNOLOGIES, INC.: COMPANY OVERVIEW 248 TABLE 326 RETRACTABLE TECHNOLOGIES, INC.: PRODUCTS OFFERED 249 TABLE 327 GREINER HOLDING AG: COMPANY OVERVIEW 250 TABLE 328 GREINER HOLDING AG: PRODUCTS OFFERED 251 TABLE 329 LIUYANG SANLI MEDICAL TECHNOLOGY DEVELOPMENT CO., LTD.: COMPANY OVERVIEW 253 TABLE 330 FL MEDICAL S.R.L.: COMPANY OVERVIEW 254 TABLE 331 AB MEDICAL CO., LTD.: COMPANY OVERVIEW 255 TABLE 332 APTACA SPA: COMPANY OVERVIEW 256 TABLE 333 JIANGSU MICSAFE MEDICAL TECHNOLOGY CO., LTD.: COMPANY OVERVIEW 257 TABLE 334 DISERA TIBBI MALZEME LOJISTIK SANAYI VE TICARET A.Ş: COMPANY OVERVIEW 257 TABLE 335 AJOSHA BIO TEKNIK PVT. LTD.: COMPANY OVERVIEW 258 TABLE 336 PREQ SYSTEMS: COMPANY OVERVIEW 259 TABLE 337 CML BIOTECH LTD: COMPANY OVERVIEW 259 TABLE 338 LMB TECHNOLOGIE GMBH: COMPANY OVERVIEW 260 TABLE 339 MITRA INDUSTRIES PRIVATE LIMITED: COMPANY OVERVIEW 260 TABLE 340 NEOMEDIC LIMITED: COMPANY OVERVIEW 261 TABLE 341 MHC MEDICAL PRODUCTS, LLC: COMPANY OVERVIEW 261 FIGURE 1 BLOOD COLLECTION DEVICES MARKET SEGMENTATION AND REGIONAL SCOPE 29 FIGURE 2 RESEARCH DESIGN 32 FIGURE 3 BLOOD COLLECTION DEVICES MARKET: KEY PRIMARY SOURCES 34 FIGURE 4 BLOOD COLLECTION DEVICES MARKET: KEY INSIGHTS FROM PRIMARIES 36 FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY- AND DEMAND-SIDE PARTICIPANTS 37 FIGURE 6 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 37 FIGURE 7 BLOOD COLLECTION DEVICES MARKET: COMPANY REVENUE ESTIMATION APPROACH 38 FIGURE 8 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 39 FIGURE 9 TOP-DOWN APPROACH 40 FIGURE 10 DATA TRIANGULATION METHODOLOGY 41 FIGURE 11 BLOOD COLLECTION DEVICES MARKET, BY PRODUCT, 2025 VS. 2030 (USD MILLION) 44 FIGURE 12 BLOOD COLLECTION DEVICES MARKET, BY METHOD, 2025 VS. 2030 (USD MILLION) 45 FIGURE 13 BLOOD COLLECTION DEVICES MARKET, BY APPLICATION, 2025 VS. 2030 (USD MILLION) 45 FIGURE 14 BLOOD COLLECTION DEVICES MARKET, BY END USER, 2025 VS. 2030 (USD MILLION) 46 FIGURE 15 BLOOD COLLECTION DEVICES MARKET, BY REGION, 2025 VS. 2030 (USD MILLION) 46 FIGURE 16 INCREASING DISEASE INCIDENCE AND DEMAND FOR BLOOD COMPONENTS TO DRIVE MARKET 47 FIGURE 17 BLOOD COLLECTION TUBES SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD 48 FIGURE 18 MANUAL BLOOD COLLECTION SEGMENT TO LEAD MARKET DURING FORECAST PERIOD 48 FIGURE 19 DIAGNOSTIC APPLICATIONS SEGMENT TO SHOWCASE LARGEST MARKET SHARE DURING FORECAST PERIOD 49 FIGURE 20 HOSPITALS, AMBULATORY SURGICAL CENTERS, AND NURSING HOMES SEGMENT TO CONTINUE TO DOMINATE MARKET IN 2030 49 FIGURE 21 NORTH AMERICAN MARKET TO ACCOUNT FOR LARGEST SHARE DURING FORECAST PERIOD 50 FIGURE 22 BLOOD COLLECTION DEVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 51 FIGURE 23 INCREASING INCIDENCE OF DIABETES, 2021 VS. 2045 (MILLION) 53 FIGURE 24 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 59 FIGURE 25 VALUE CHAIN ANALYSIS: MAJOR VALUE ADDED DURING MANUFACTURING AND ASSEMBLY PHASES 62 FIGURE 26 SUPPLY CHAIN ANALYSIS: DIRECT DISTRIBUTION TO BE PREFERRED STRATEGY FOR PROMINENT COMPANIES 63 FIGURE 27 BLOOD COLLECTION DEVICES MARKET: ECOSYSTEM ANALYSIS 65 FIGURE 28 BLOOD COLLECTION DEVICES MARKET: INVESTMENT AND FUNDING SCENARIO, 2020−2023 65 FIGURE 29 BLOOD COLLECTION DEVICES MARKET: PATENT ANALYSIS, JANUARY 2014–DECEMBER 2024 67 FIGURE 30 BLOOD COLLECTION DEVICES MARKET: PORTER’S FIVE FORCES ANALYSIS 78 FIGURE 31 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY END USER 80 FIGURE 32 KEY BUYING CRITERIA, BY END USER 80 FIGURE 33 AI USE CASES 82 FIGURE 34 NORTH AMERICA: BLOOD COLLECTION DEVICES MARKET SNAPSHOT 144 FIGURE 35 ASIA PACIFIC: BLOOD COLLECTION DEVICES MARKET SNAPSHOT 181 FIGURE 36 REVENUE ANALYSIS OF KEY PLAYERS IN BLOOD COLLECTION DEVICES MARKET, 2022–2024 209 FIGURE 37 BLOOD COLLECTION DEVICES MARKET SHARE ANALYSIS, 2024 210 FIGURE 38 EV/EBITDA OF KEY VENDORS 211 FIGURE 39 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS 211 FIGURE 40 BLOOD COLLECTION DEVICES MARKET: BRAND/PRODUCT COMPARISON 212 FIGURE 41 BLOOD COLLECTION DEVICES MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024 213 FIGURE 42 BLOOD COLLECTION DEVICES MARKET: COMPANY FOOTPRINT 214 FIGURE 43 BLOOD COLLECTION DEVICES MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024 217 FIGURE 44 BECTON, DICKINSON AND COMPANY (BD): COMPANY SNAPSHOT 222 FIGURE 45 TERUMO BCT, INC.: COMPANY SNAPSHOT (2023) 227 FIGURE 46 FRESENIUS KABI AG: COMPANY SNAPSHOT (2024) 231 FIGURE 47 GRIFOLS, S.A.: COMPANY SNAPSHOT (2024) 235 FIGURE 48 NIPRO CORPORATION: COMPANY SNAPSHOT (2024) 237 FIGURE 49 HAEMONETICS CORPORATION: COMPANY SNAPSHOT (2024) 241 FIGURE 50 ICU MEDICAL, INC.: COMPANY SNAPSHOT (2024) 244 FIGURE 51 CARDINAL HEALTH: COMPANY SNAPSHOT (2024) 246 FIGURE 52 RETRACTABLE TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2024) 249 FIGURE 53 GREINER HOLDING AG: COMPANY SNAPSHOT (2024) 251

同分類最新報告（醫療器材）

查看醫療器材全部報告 →

量子訊息有限公司為 MarketsandMarkets 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們